Atlas FDA

Exablate Model 4000 Type 1.0 and 1.1 System (“Exablate Neuro”)

FDA premarket approval P150038/S024 · decided 2022-11-11

Approval details

PMA number
P150038
Supplement
S024
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
Exablate Model 4000 Type 1.0 and 1.1 System (“Exablate Neuro”)
Generic name
MR-guided focused ultrasound system
Applicant
Insightec
Date received
2022-10-12
Decision date
2022-11-11
Days to decision
30 days
Decision code
APPR
Product code
POH
Advisory committee
Neurology
Expedited review
No
Location
Tirat Carmel
Statement
Approval of the revised protocol for the post-approval study (PAS) protocol.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.